By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Lysogene 

52 rue de la Boétie

  Paris  75008   France
Phone: 33-0-1-56-88-52-86 Fax: 33-0-1-56-88-52-81


SEARCH JOBS


Industry
Biotechnology






Company News
Lysogene Announces Selection Of MRI Interventions (MRIC)’ Smartflow Cannula For Phase II/III Clinical Study In MPS IIIA 4/20/2017 11:05:00 AM
Lysogene Announces Baseline Data From First International Pivotal Observational Study In MPS IIIA 3/28/2017 11:21:51 AM
Lysogene Receives Orphan Drug Designation From EMA For LYS-GM101 For Treatment Of GM1 Gangliosidosis 2/21/2017 10:15:19 AM
Lysogene Receives Orphan Drug Designation From FDA For LYS-GM101 For Treatment Of GM1 Gangliosidosis 2/3/2017 8:34:50 AM
Lysogene Release: Biotech Receives Rare Pediatric Disease Designation From FDA For LYS-GM101 For Treatment Of GM1 Gangliosidosis 1/18/2017 7:31:40 AM
Lysogene Appoints David Schilansky To Board Of Directors 12/8/2016 10:20:42 AM
Lysogene Expands Senior Leadership In The USA To Support Its International Development Strategy 10/3/2016 11:28:52 AM
Lysogene Begins Multi-National Observational Study As It Prepares To Initiate Pivotal Clinical Trial For The Treatment Of Sanfilippo Type A 7/6/2016 10:13:18 AM
Lysogene Appoints Dr. Kimberley S. Gannon As Chief Scientific Officer 6/20/2016 9:34:18 AM
Lysogene Creates A Medical And Regulatory Department 2/2/2016 11:52:28 AM
12
//-->